October is National Liver Cancer Awareness Month. Join our webinar to discuss how community health centers can use cost-benefit analysis to establish enhanced hepatitis C virus (HCV) screening and testing programs to avoid long-term health impacts for patients. Beginning with a discussion of national trends in HCV rates and an overview of the Viral Hepatitis Action Plan, this webinar features Dr. Michael Halpern from Temple University about cost-benefit analysis and how to apply this method to HCV screening, testing, and treatment within community health centers.
As the Hepatitis C virus (HCV) infection is emerging as a serious public health problem in tandem with the opioid epidemic, health centers have the opportunity to decrease its impact with standardized screening, linkage to care and treatment protocols. This case study highlights how five health centers nationally are addressing the increased rates of HCV infection and its intersection with the opioid epidemic.
This webinar provides a national perspective of how the hepatitis C virus (HCV) and opioid use disorder epidemics are connected and what health centers can do to address them. We heard from Lauren Canary from the CDC about expansion of medication-assisted treatment (MAT) and what resources are available to providers.
NASTAD discusses the current landscape of opioid and infectious disease and resources available for health settings to improve screening, testing, and treatment options for patients.
Iowa Department of Public Health will review current substance use disorder rates in Iowa and surveillance to eliminate HIV and HCV throughout the state. The Clinician Consultation Network of University of California San Francisco will review resources available for providers treating hepatitis and co-occurring substance use orders, such as the Warm Line for consultation of cases.
Community College of Philadelphia Nursing Department will discuss the history of community nursing and how nursing students have increased awareness of opioid use disorder and Narcan training throughout Philadelphia. Public Health Management Corporation will explain the expansion of Medication-Assisted Therapy in Rising Sun Health Center and resources for organizations to increase provider capacity.
NNCC partnered with the Philadelphia Department of Public Health and Hepatitis B Foundation to increase viral hepatitis education, screening and vaccination access, and enhanced treatment capacity for HepB in Philadelphia. During the presentation, we reviewed HepB epidemiology in Philadelphia, Department of Public Health Programming, HepB screening processes and resources, and vaccination schedules for HepB.
NNCC partnered with the Philadelphia Department of Public Health and Hepatitis B Foundation to increase viral hepatitis education, screening and vaccination access, and enhanced treatment capacity for HepB in Philadelphia. During the presentation, NNCC reviewed global elimination plans for HepB, overview of viral hepatitis, risk factors, screening for pregnant women, vaccination schedules for children and adults, and a Resource Guide for Viral Hepatitis.
